An exclusive interview with Philippe Mengal, Director of BBI JU. “The bio-based sector can be a key contributor to the Europe’s recovery”

Philippe Mengal

“I am convinced that this crisis will teach us many lessons and I am sure that the day after will find us working together to kick-star again our economies and drive our recovery towards a more resilient, green and digital EU.” Philippe Mengal, Executive Director of BBI JU, talks to Il Bioeconomista. In this exclusive interview, he tells us how the European bioeconomy is reacting to the crisis of coronavirus.

Interview by Mario Bonaccorso

Continue reading

International investors call for governments to work towards a sustainable recovery from COVID

A picture from the Bioeconomy Investment Summit 2017 in Helsinki

International investor groups, including the Asia Investor Group on Climate Change (AIGCC), have encouraged global governments to ensure they are planning for a sustainable recovery from the COVID-19 pandemic by factoring in climate change risk into economic recovery plans.

Continue reading

Swiss Syngenta and Danish Novozymes join forces to commercialize the biofungicide Taegro

Syngenta and Novozymes are entering the commercialization phase of the biofungicide Taegro. The two companies originally joined forces in 2012 to develop and market the product, and have now received the first wave of product approvals in Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Honduras, Italy, Netherlands, Romania, Slovenia, Spain, and United Kingdom. Several other approvals are expected across the EU and Latin America during the next 12 months, which will enable multiple product launches in 2020.

Continue reading

Braskem is securing the supply of polypropylene polymers for the production of respiratory masks and protective medical gear

Braskem, producer of polyolefins and biopolymers, is meeting the polypropylene raw material needs of medical manufacturing customers for the production of respiratory masks as well as protective medical gear.

Continue reading

“The bioeconomy gives us new tools and opportunities to exploit this chaotic time”. An interview with Tony Duncan, CEO Circa Group

Tony Duncan, CEO of Circa Group, at IFIB 2018 in Turin

“Within the bioeconomy we have a massive range of new tools and opportunities to exploit this chaotic time.” To say it – in this long exclusive interview with Il Bioeconomista – is Tony Duncan, CEO of Circa Group, the Australia-based biochemical company, which is revolutionizing the traditional chemical sector. With him we talk about his company and the bioeconomy in the COVID-19 age.

Interview by Mario Bonaccorso

Continue reading

In Brussels launched an alliance for a green recovery from the Covid-19 pandemic

European Parliament, Brussels

An alliance has been launched in the European Parliament on the back of calls from 12 EU environment ministers who have signed an appeal for a green recovery from the COVID-19 pandemic. The “green recovery alliance” was launched last Monday at the initiative of Pascal Canfin, a French centrist MEP who chairs the European Parliament’s committee on environment and public health.

Continue reading

Nouryon introduced a natural film-forming polymer for use in high SPF emulsion sunscreens

Nouryon introduced a natural film-forming polymer for use in high sun protection factor (SPF) emulsion sunscreens. SolAmaze™ Natural, which is bio-based and readily biodegradable, addresses the fast-growing consumer demand for natural and clean label ingredients in personal care products.

Continue reading

Clariant started monthly production of 2 million liters of disinfectant using bioethanol

Hariolf Kottmann, Ceo of Clariant

Clariant, a focused and innovative specialty chemical company, today announced it has started monthly production of 2 million liters of disinfectant at its facilities in Gendorf, Germany. This disinfectant is then directly or via repacking partners provided to regional hospitals and other vital institutions in Bavaria, who are currently facing limited availability of this critical product during the COVID-19 outbreak.

Continue reading

A Story from the Near Future

It’s awesome! The emergency is finally over. We can go back to our life. The virus was defeated without waiting for the vaccine, because we all behaved in the best way, staying at home and respecting the physical distance. Now we can go back to meet, talk to each other and, if necessary, also to hug. We’ll always remember all the dead people and the sufferings. And also the physicians and nurses and all the people who spent themselves on others.

Continue reading

DSM completed its acquisition of Glycom to grow in the Early Life Nutrition solutions

Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, completed its acquisition of Glycom A/S, the world’s leading supplier of Human Milk Oligosaccharides (HMO) for an enterprise value of €765 million.

Continue reading